First: Injectable GHK-Cu Is Not FDA Approved GHK-Cu is a copper-binding tripeptide studied for tissue remodeling, wound healing, collagen signaling, and anti-inflammatory pathways
Glutathione can lighten skin by reducing melanin production, but the results are not permanent
Important Considerations for Combination Dosing Several critical factors would need consideration for cagrilintide dosing alongside tirzepatide: Overlapping side effects Both peptides slow gastric emptying and can cause nausea Individual variability Response to peptides varies significantly between individuals Monitoring requirements Regular assessment of tolerability and metabolic markers Dose adjustment flexibility Willingness to reduce either peptide if side effects emerge Clinical supervision Medical oversight essential for any combination approach For those researching metabolic peptides, exploring resources on peptide synergy can provide valuable insights into combination approaches
Simon, E., Vogel, M., Fingerhut, R., Ristoff, E., Mayatepek, E